Submitted by: Submitted by dannydiazion
Views: 71
Words: 997
Pages: 4
Category: Business and Industry
Date Submitted: 11/21/2014 10:37 AM
Global Irritable Bowel Syndrome Market 2015-2019
About Irritable Bowel Syndrome
Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. According to the CDC, prominent symptoms of irritable bowel syndrome include severe bloating, severe stomach cramps or abdominal pain, lower back pain, groin pain, heartburn, acidity, shooting pain in the legs, and lightheadedness after eating.
Browse Complete Report with TOC: http://www.marketresearchstore.com/report/global-irritable-bowel-syndrome-market-2015-2019-1549
TechNavio's analysts forecast the Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Irritable Bowel Syndrome market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of irritable bowel syndrome.
TechNavio's report, Global Irritable Bowel Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Irritable Bowel Syndrome market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Buy this Report: http://www.marketresearchstore.com/checkout/reportId/1549/reportType/0
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Actavis
• Astellas Pharma
• Nestle
•...